Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,912 | 54,093 | 82,152 | 80,738 | 246,017 |
| Marketable Securities | 327,241 | 385,925 | 386,371 | 179,262 | 30,082 |
| TOTAL | $410,938 | $444,753 | $475,374 | $265,863 | $279,781 |
| Non-Current Assets | |||||
| PPE Net | 4,472 | 3,504 | 2,683 | 2,640 | 2,706 |
| Other Non-Current Assets | 20,514 | 13,245 | 2,764 | 2,331 | 2,264 |
| TOTAL | $24,986 | $16,749 | $5,447 | $4,971 | $4,970 |
| Total Assets | $435,924 | $461,502 | $480,821 | $270,834 | $284,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,782 | 7,589 | 2,739 | 6,014 | 5,196 |
| Accrued Expenses | 13,570 | 8,489 | 11,659 | 10,660 | 8,986 |
| TOTAL | $33,836 | $22,137 | $14,398 | $16,674 | $14,182 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,666 | 4,433 | 230 | 0 | 0 |
| TOTAL | $4,666 | $4,433 | $230 | $N/A | $N/A |
| Total Liabilities | $38,502 | $26,570 | $14,628 | $16,674 | $14,182 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,831 | 123,514 | 123,420 | 123,170 | 95,592 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -457,557 | -410,006 | -372,760 | -340,185 | -306,355 |
| Other shareholders' equity | 372 | 138 | -42 | -120 | -3 |
| TOTAL | $397,422 | $434,932 | $466,193 | $254,160 | $270,569 |
| Total Liabilities And Equity | $435,924 | $461,502 | $480,821 | $270,834 | $284,751 |